Here, we generated an original peptide, A1-IRS, derived from Angel1, a partner of eIF4E that we recently identified.14 The A1-IRS peptide interacts with eIF4E, inhibits in vitro translation and, surprisingly, provokes rapid and massive cell death in a wide variety of cancer cell lines. Here, ANGEL1 is linked to cancer.